Szabolcs Szarka
Research Subjects
Szabolcs Szarka has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Robert Wheller
Resolian
3 shared publications Richard Lucey
AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, Cambridge, United Kingdom
2 shared publicationsAlina Pruna
DDS (Drug Development Solutions), Newmarket Rd, Fordham, CB7 5WW, United Kingdom
1 shared publicationAmanda Wilson
Labcorp, Bioanalytical Services, Harrogate, United Kingdom
1 shared publicationAna Villar Garea
Sanofi – R&D, Translational Medicine Unit, Frankfurt am Main, Germany
1 shared publication- Andrew Robert Pitt
Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, Department of Chemistry, University of Manchester, Manchester, UK
1 shared publication
Latest Publications
- 3 May 2026
- Published by Taylor & Francis in Bioanalysis
- Vol. 18 (7) , 561-569
Fit-for-purpose application of LC–MS in protein bioanalysis, case studies shared within the European Bioanalysis Forum Hybrid MS team
The use of liquid chromatography-mass spectrometry for quantitative large-molecule bioanalysis has increased substantially over the past decade, driven by its ability to address analytical challenges that may be difficult to resolve using traditional ligand-binding assays. In this European Bioanalysis Forum perspective, seven case studies from pharmaceutical companies and contract research organizations illustrate the fit-for-purpose application of LC-MS across different stages of drug development. These include isoform-specific quantification, subclass-resolved immunoglobulin profiling, characterization of post-translational modifications, assessment of in vivo biotherapeutic integrity, and multiplexed analysis in complex biological matrices. Collectively, the examples highlight how LC-MS can support selectivity, structural insight, and analytical flexibility when aligned with the specific context of use. The EBF aims to foster continued scientific exchange by encouraging the sharing of such case studies across its community.
- 3 May 2026
- Published by Taylor & Francis in Bioanalysis
- Vol. 18 (7) , 561-569
Fit-for-purpose application of LC–MS in protein bioanalysis, case studies shared within the European Bioanalysis Forum Hybrid MS team
The use of liquid chromatography-mass spectrometry for quantitative large-molecule bioanalysis has increased substantially over the past decade, driven by its ability to address analytical challenges that may be difficult to resolve using traditional ligand-binding assays. In this European Bioanalysis Forum perspective, seven case studies from pharmaceutical companies and contract research organizations illustrate the fit-for-purpose application of LC-MS across different stages of drug development. These include isoform-specific quantification, subclass-resolved immunoglobulin profiling, characterization of post-translational modifications, assessment of in vivo biotherapeutic integrity, and multiplexed analysis in complex biological matrices. Collectively, the examples highlight how LC-MS can support selectivity, structural insight, and analytical flexibility when aligned with the specific context of use. The EBF aims to foster continued scientific exchange by encouraging the sharing of such case studies across its community.
- 19 May 2025
- Published by Taylor & Francis in Bioanalysis
- Vol. 17 (10) , 641-650
Design of experiments for the optimization of sample preparation for bottom-up targeted protein LC-MS/MS workflows
Design of experiments (DOE) is a versatile and efficient approach to tackle complex scientific problems. We aimed to assess its feasibility in the optimization of the multistep, involved bottom-up sample preparation for the UPLC-MS/MS analysis of proteins. The model analyte was a human IgG1 monoclonal antibody which was spiked into rat plasma and processed further by reduction, alkylation, and digestion for the subsequent UPLC-MS/MS analysis. The Modde Go software was used for the generation of experimental designs and for processing, analyzing and the interpretation of the data. DOE screening revealed that urea made the biggest improvement on the surrogate peptide responses, while guanidine significantly suppressed them. DOE optimization resulted in a 2-, 10-, 10- and 50-fold response increase for the respective DTLM, FNWY, TPEV and VVSV surrogate peptide even after a short, <3-h sample preparation, when compared to a legacy method that required 2-day preparation. The DOE approach was applied successfully for the comprehensive optimization of eight denaturation, reduction and digestion parameters. DOE was found to be an efficient tool for protein sample preparation optimization, and the predictive power of the DOE models was successfully demonstrated.
- 19 May 2025
- Published by Taylor & Francis in Bioanalysis
- Vol. 17 (10) , 641-650
Design of experiments for the optimization of sample preparation for bottom-up targeted protein LC-MS/MS workflows
Design of experiments (DOE) is a versatile and efficient approach to tackle complex scientific problems. We aimed to assess its feasibility in the optimization of the multistep, involved bottom-up sample preparation for the UPLC-MS/MS analysis of proteins. The model analyte was a human IgG1 monoclonal antibody which was spiked into rat plasma and processed further by reduction, alkylation, and digestion for the subsequent UPLC-MS/MS analysis. The Modde Go software was used for the generation of experimental designs and for processing, analyzing and the interpretation of the data. DOE screening revealed that urea made the biggest improvement on the surrogate peptide responses, while guanidine significantly suppressed them. DOE optimization resulted in a 2-, 10-, 10- and 50-fold response increase for the respective DTLM, FNWY, TPEV and VVSV surrogate peptide even after a short, <3-h sample preparation, when compared to a legacy method that required 2-day preparation. The DOE approach was applied successfully for the comprehensive optimization of eight denaturation, reduction and digestion parameters. DOE was found to be an efficient tool for protein sample preparation optimization, and the predictive power of the DOE models was successfully demonstrated.
- 17 April 2023
- Published by Elsevier in Journal of Chromatography A
- Vol. 1699, 464002
Development and validation of a liquid chromatography-triple quadrupole mass spectrometry method for the determination of isopeptide ε-(γ-glutamyl) lysine in human urine as biomarker for transglutaminase 2 cross-linked proteins
- 17 April 2023
- Published by Elsevier in Journal of Chromatography A
- Vol. 1699, 464002
Development and validation of a liquid chromatography-triple quadrupole mass spectrometry method for the determination of isopeptide ε-(γ-glutamyl) lysine in human urine as biomarker for transglutaminase 2 cross-linked proteins
- 11 April 2023
- Published by Taylor & Francis in Bioanalysis
- Vol. 15 (7) , 391-405
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?
Aims: The drive toward more sensitive LC–MS assays has resulted in long, complex methods. We assessed next-generation trypsins to identify a suitable candidate to integrate into protein LC–MS metho... Tweetable abstract Tired of long protein LC–MS methods? We assess next-generation trypsins for rapid LC–MS Bioanalysis!
- 11 April 2023
- Published by Taylor & Francis in Bioanalysis
- Vol. 15 (7) , 391-405
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?
Aims: The drive toward more sensitive LC–MS assays has resulted in long, complex methods. We assessed next-generation trypsins to identify a suitable candidate to integrate into protein LC–MS metho... Tweetable abstract Tired of long protein LC–MS methods? We assess next-generation trypsins for rapid LC–MS Bioanalysis!
- 20 February 2015
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 50 (3) , 533-537
Chip‐based nanoelectrospray ionization with Fourier transform mass spectrometric detection to screen for local anesthetics intended to mask limb sore in walking horses
We report a high‐throughput chip‐based nanoelectrospray ionization method coupled with Fourier transform mass spectrometry to screen for local anesthetics in samples collected by swabbing. These drugs have been used to mask pain on the limbs of walking horses after forbidden practices of soring or physical abuse. Optimized for lidocaine, the method afforded sub‐ppm mass accuracy for nine local anesthetics included in the study. From doped cotton swabs, two third and all of the analytes were detected after adding 10 ng and 100 ng of each drug, respectively. Benzocaine and/or lidocaine were found on positive swab samples collected during walking horse competitions. Copyright © 2015 John Wiley & Sons, Ltd.
- 20 February 2015
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 50 (3) , 533-537
Chip‐based nanoelectrospray ionization with Fourier transform mass spectrometric detection to screen for local anesthetics intended to mask limb sore in walking horses
We report a high‐throughput chip‐based nanoelectrospray ionization method coupled with Fourier transform mass spectrometry to screen for local anesthetics in samples collected by swabbing. These drugs have been used to mask pain on the limbs of walking horses after forbidden practices of soring or physical abuse. Optimized for lidocaine, the method afforded sub‐ppm mass accuracy for nine local anesthetics included in the study. From doped cotton swabs, two third and all of the analytes were detected after adding 10 ng and 100 ng of each drug, respectively. Benzocaine and/or lidocaine were found on positive swab samples collected during walking horse competitions. Copyright © 2015 John Wiley & Sons, Ltd.